COVID-19 continues to explore new avenues to infiltrate human cells, accumulating mutations as it progresses in its evolutionary journey. The pace and trajectory of this evolution are highly alarming. A recent study published on January 16, 2024, sheds light on some troubling developments in the earlier phases of the Omicron variant's evolution. It reveals that variants such as BA.4 and BA.5 display enhanced abilities to evade the body's natural defenses compared to predecessors like BA.1 and BA.2. This worrisome trend persists with each subsequent evolutionary leap, as seen with variants like KP.2, which boasts a staggering 45 mutations distinct from XBB.1.5. The sheer accumulation of mutations underscores a clear narrative: the virus is acquiring new capabilities as it adapts.
The Cleveland Clinic study didn’t show causation for risks going up after the booster. For any later studies it would make sense for boosted people to be at higher risk after 3 months because only higher risk people are getting boosted at this point.
And if it is a concern for MRNA, it’s not a concern for Novavax, which is the superior vaccine from what I’ve read.
The Cleveland Clinic study didn’t show causation for risks going up after the booster. For any later studies it would make sense for boosted people to be at higher risk after 3 months because only higher risk people are getting boosted at this point.
And if it is a concern for MRNA, it’s not a concern for Novavax, which is the superior vaccine from what I’ve read.